Is this your firm? Get featured or correct your listing →
At a glance
DeepWork Capital appears in 2 funding rounds tracked by ValueAddVC since 2025, leading 1. Its most recent tracked deal was Astrocyte Pharmaceuticals' $9.5M Series B round (Sep 30, 2026).
Strategy
Recent changes
- Sep 30, 2026Sep 30, 2026Invested in Astrocyte Pharmaceuticals (Series B, $9.5M) Pulse 2.0
Portfolio
2 totalRecent Investment Activity
2Track record: led 1 and participated in 1 of 2 tracked venture rounds · 2 in the last 12 months · led 1 Series B
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Astrocyte Pharmaceuticals | Series B | Led | $9.5M | — | DeepWork CapitalLeadunverifiedMintPharma CapitalWaterstar CapitalDynagrow CapitalAngel Star Ventures | Pulse 2.0 |
| Nov 12, 2025 | Exowatt | Series A extension | Participated | $50M | — | MVP VenturesLeadunverified8090 IndustriesLeadunverifiedFelicis VenturesunverifiedFlorida Opportunity FundunverifiedDeepWork CapitalunverifiedStepStone GroupunverifiedAtomicunverified | Business Wire |
Sector / Stage Activity
Co-Investors
5Similar Firms
overlapping sector, stage or regionValue Add Research
DeepWork Capital FAQ
What companies has DeepWork Capital invested in?
DeepWork Capital's portfolio includes Astrocyte Pharmaceuticals, Exowatt.
Who does DeepWork Capital co-invest with most?
In the rounds Value Add tracks, DeepWork Capital most often invests alongside 8090 Industries (1 shared deal), Atomic (1 shared deal), Felicis Ventures (1 shared deal), MVP Ventures (1 shared deal), StepStone Group (1 shared deal).
Sources & methodologyshow
- Business Wireprimary source1 fact
- Pulse 2.0Value Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.